SCHEMBL14675569

SCHEMBL14675569

COc1ccc2c(c1)NC(=O)/C2=C/c1ccccc1F

nearest known ligand 0.65

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NPC1 O15118 2/20 0.65
▸ MDM2 Q00987 4/20 0.64
▸ TLK2 Q86UE8 2/20 0.61
▸ PDGFRB P09619 3/20 0.56
▸ CSNK1A1 P48729 3/20 0.56
▸ NTRK1 P04629 2/20 0.56
▸ KDR P35968 2/20 0.56
▸ PRKD3 O94806 1/20 0.56
▸ ABL1 P00519 1/20 0.56
▸ RET P07949 1/20 0.56
▸ LTK P29376 1/20 0.56
▸ MAP2K2 P36507 1/20 0.56
▸ FLT3 P36888 1/20 0.56
▸ CDK8 P49336 1/20 0.56
▸ CDK7 P50613 1/20 0.56
▸ MAP2K1 Q02750 1/20 0.56
▸ MST1R Q04912 1/20 0.56
▸ NTRK3 Q16288 1/20 0.56
▸ NTRK2 Q16620 1/20 0.56
▸ AURKB Q96GD4 1/20 0.56

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14675570 1.00 NPC1 (0.65) NPC1MDM2TLK2PDGFRBCSNK1A1
SCHEMBL14521137 0.87 NPC1 (0.61) NPC1MDM2TLK2PDGFRBCSNK1A1
SCHEMBL5472882 0.85 MDM2 (0.72) NPC1MDM2PDGFRBCSNK1A1NTRK1
SCHEMBL5472879 0.85 MDM2 (0.72) NPC1MDM2PDGFRBCSNK1A1NTRK1
SCHEMBL14448957 0.85 MDM2 (0.72) NPC1MDM2PDGFRBCSNK1A1NTRK1
SCHEMBL14674463 0.84 MDM2 (0.58) NPC1MDM2TLK2PDGFRBCSNK1A1
SCHEMBL14674464 0.84 MDM2 (0.58) NPC1MDM2TLK2PDGFRBCSNK1A1
SCHEMBL14659989 0.83 MDM2 (0.59) NPC1MDM2TLK2PDGFRBCSNK1A1
SCHEMBL14659990 0.83 MDM2 (0.59) NPC1MDM2TLK2PDGFRBCSNK1A1
SCHEMBL14679964 0.83 NPC1 (0.70) NPC1MDM2PDGFRBKDRRET

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20130035364-A1 BENZYLIDENE-INDOLINONE COMPOUNDS AND THEIR MEDICAL USE NATIONAL UNIVERSITY OF SINGAPORE (SG) 2013-02-07 — — US claimed
US-8877946-B2 Benzylidene-indolinone compounds and their medical use NATIONAL UNIVERSITY OF SINGAPORE (SG) 2014-11-04 — — US disclosed
US-8877946-B2 Benzylidene-indolinone compounds and their medical use NATIONAL UNIVERSITY OF SINGAPORE (SG) 2014-11-04 — — US disclosed
US-20130035364-A1 BENZYLIDENE-INDOLINONE COMPOUNDS AND THEIR MEDICAL USE NATIONAL UNIVERSITY OF SINGAPORE (SG) 2013-02-07 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130035364-A1 BENZYLIDENE-INDOLINONE COMPOUNDS AND THEIR MEDICAL USE ERBB2, ABL1, IGF1R NPC1 2370/4885MDM2 1030/4885TLK2 1344/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback